Coronary stenting: the appropriate use of FFR Morton J. Kern, MD Professor of Medicine Chief of Cardiology LBVA Associate Chief Cardiology University California.

Slides:



Advertisements
Similar presentations
IVUS Use during Left Main PCI improve Immediate and Long Term Outcome Where is the Evidence? E Murat Tuzcu, MD, FACC Professor of Medicine Vice Chairman.
Advertisements

FFR & IVUS PRIOR TO REVASCULARISATION Journal review Dr. Sony Manuel M Senior Resident MCH Kozhikode.
FFR & IVUS PRIOR TO REVASCULARISATION Journal review Dr.Sony Manuel M Senior Resident MCH Kozhikode.
FFR et bifurcation. FFR et MB avant ATL MB SB ? 1.Intermediate stenoses (Pijls et al. New Engl J Med 1996) (Pijls et al. JACC 2010) 2.Post-myocardial.
Cardiology Morning Report: Revascularization in Stable Ischemic Heart Disease Bobby Mathew, MD LSU Internal Medicine, HO-II.
FRACTIONAL FLOW RESERVE versus ANGIOGRAPHY
FFR vs Angiography for Multivessel Evaluation
FAME 2 year Objective:To investigate the 2-year outcome of PCI guided by FFR in patients with multivessel CAD. Study:Multicenter, single blind, randomized.
FAME 2 Report of the Primary Endpoint
To stent or not to stent Clinical Utility of Fractional Flow Reserve.
Journal : Evidence Review PCI : Role of FFR Dr Binjo J Vazhappilly SR Cardiology MCH Calicut.
Educational Training Program ESC European Heart House, Nice, April 19 th –21st, 2007 CORONARY PHYSIOLOGY IN THE CATHLAB LONG-TERM CLINICAL OUTCOME OF MILD.
2 Year Clinical Outcomes from the Pivotal RESOLUTE US Study Laura Mauri MD, MSc on behalf of the RESOLUTE US Investigators Brigham and Women’s Hospital.
29th ANNUAL SCIENTIFIC SESSIONS – SCA&I
CORONARY PRESSURE MEASURENT AND FRACTIONAL FLOW RESERVE
DEFER STUDY: 5-YEAR FOLLOW-UP A Multicenter Randomized Study
FFR Going Beyond Angiography
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
FFR in specific circumstances Zsolt Piróth MD Gottsegen György Hungarian Institute of Cardiology.
Is FFR a Substitute For Sound Clinical Judgement ? Jeffrey W. Moses, MD Columbia University Medical Center/ NY-Presbyterian Hospital.
REVASCULARIZATION Vs MEDICAL THERAPY IN STABLE CAD
Tips and Pitfalls in Measurement of FFR during Bifurcation Stenting Nanjing first hospital Nanjing cardiovascular hospital Yefei Chenshaoliang Zhangjunjie.
Unstable angina and arterial hypertension Leszek Kinasz, MD American Heart of Poland Ustron, Poland.
Multi-vessel disease and intracoronay physiology Combat MI 2009 Kees-joost Botman MD, PhD Catharina hospital Eindhoven Heart Institute The Netherlands.
Appropriate Use Criteria are Inappropriately Used Jeffrey W. Moses, MD.
RITA-3 Is this a benign lesion in a benign condition? Who Needs Angioplasty in 2008? Stable Angina Stable Angina Keith A A Fox Professor of Cardiology.
Jie Qian National Heart Center & FuWai Hospitall FFR in Diffuse Multivessel Disease.
Pressure Wire Evaluation of the Left Main Stem Dr Phil MacCarthy Consultant Cardiologist King’s Cardiac Centre Left Main 5+ at AA2007, Jan 24 th, 2007.
SIROLIMUS-ELUTING STENTS EFFECTIVELY INHIBIT NEOINTIMAL PROLIFERATION AS COMPARED TO BARE METAL STENTS IN DISEASED SAPHENOUS VEIN GRAFTS: 6-month IVUS.
PCI Myocardial Revascularization Prof. Yean L. Lim AM 5 th Ningxia ICF 2014.
Pathophysiology of the coronary circulation: role of FFR Giuseppe Biondi Zoccai University of Modena and Reggio Emilia, Modena, Italy
Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients with Stable Coronary Disease: Results from the FAME.
Case report of FFR for bifurcation Nanjing first hospital Nanjing heart center Yefei chenshaoliang.
Is the Decision-Making after Failure of CTO Angioplasty Same? Infarct Related CTO or Non- Infarct Related CTO (Continue the Procedure in Other Vessel or.
ADMIRALADMIRAL Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long term follow-up ADMIRAL Study ADMIRAL.
New strategies and perfusion/aspiration devices for primary PCI Sandra Garcia Cruset, PhD. Cordynamic B.U. Marketing Manager.
Coronary Stenting: Everyone should be using FFR Morton J. Kern, MD Chief of Medicine, VA Long Beach HCS Professor of Medicine University California Irvine.
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki.
Left Main PCI: What is Best Practice? Ayman A. Magd, MD FSCAI Board of Trustees of SCAI Board of Trustees of SCAI Professor of Cardiology, Azhar University.
Multivessel PCI in an Era of Freedom and FAME Michael J. Cowley, MD, FSCAI Nothing to Disclose.
Columbia University Medical Center Cardiovascular Research Foundation New York City, NY Akiko Maehara, MD Use of IVUS Reduces Stent Thrombosis and Myocardial.
Afsane mohammadi,MD Interventional cardiologist.  The presence of inducible ischemia is an important risk factor for adverse outcome.the more inducible.
Left Main PCI: What is Best Practice? Theodore A Bass, MD FSCAI, FACC President-Elect SCAI Professor of Medicine, University of Florida Medical Director.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Fractional Flow Reserve Versus Angiography for Guiding.
Intravascular ultrasound (IVUS) in percutaneous coronary intervention – summary of key articles While angiography is routinely used for assessment of CAD,
Intravascular ultrasound (IVUS) in the treatment of long and diffuse lesions– summary of key articles Prepared by Radcliffe Cardiology 21 November2016.
Simplifying Serial Lesion Assessment
Fractional Flow Reserve: How to use FFR in 2015
Methods for Hyperemic Assessment of FFR
Forget IVUS and OCT; Everyone Should Be Using FFR
FFR DECISION MAKING DURING DIAGNOSTIC PROCEDURES
Viewed in 117 Countries. Viewed in 117 Countries.
Nico H.J. Pijls, William F. Fearon, Peter Jüni, and Bernard De Bruyne
IVUS, FFR, OCT- Which Should I Use For PCI?
Physiologic Lesion Assessment: Advantages and Pitfalls
Clinical Usefulness of Post-Stenting FFR
The Starting Point: Translesional Pressure versus Flow
Solved & Unsolved Issues
The Winking Saphenous Vein Graft: Acute Aorto-Vein Graft Anastomotic Torsional Kink causing Dynamic Systolic Compression Complicating Vein Graft PCI Dr.
9:00 AM-9:05 AM, Tuesday, Oct. 31; Room 201/203
Physiological Assessment of Left Main Coronary Artery Disease
When IVUS? When FFR? Assessing Intermediate Lesions
Debate: What Does the Future Hold for the Treatment of Unprotected Left Main Disease? More PCI No More Routine Surgery Ron Waksman, MD, FACC Washington.
The Guidelines Should Be Change!
Fractional Flow Reserve Workshop
Catheter-Based Treatment of Coronary Artery Disease
71 yo Man with typical angina, pos stress, CAD risk factors
3-Year Clinical Outcomes From the RESOLUTE US Study
Maintenance of Long-Term Clinical Benefit with
Presentation transcript:

Coronary stenting: the appropriate use of FFR Morton J. Kern, MD Professor of Medicine Chief of Cardiology LBVA Associate Chief Cardiology University California Irvine Orange, California

To treat or not to treat? Is this lesion producing Ischemia? Is PCI appropriate for situation?

The rationale for using coronary physiology is the inability of the 2D images of angiogram to accurately depict the 3D lesion characteristics limiting flow. 75% Dia 20% Dia

Uncertainty in Critical Angiographic Based Decisions Intermediate Stenosis, no evidence ischemia Left Main Stenosis Multivessel CAD Serial Lesions Ostial and Branch Disease

Aortic, Pa Coronary, Pd FFR= Pd/Pa = 65/90 = 0.72 Measurement of FFR correlates to the results of stress testing and ischemia out of the lab. FFR is a ‘stress test’ for that artery in the lab at time of cath. Adenosine Resting pressures

5 Steps to Accurate FFR 1.Zero guide and wire on table to atmosphere 2.Insert wire into guide and match wire/guide pressures in aorta 3.Cross lesion 2-3cm distal 4.Turn on IV adenosine 2-4 minutes 5.Confirm accuracy with pressure pull back

Rely on FFR Avoid pitfalls of pressure and FFR Technical loose connections loose connections Improper zero Improper zero Calibration offset Calibration offsetAnatomic Extreme tortuosity Extreme tortuosity Inability to wire vesselInability to wire vessel SpasmSpasmMechanical Wire/artery impact Pharmacologic Inadequate hyperemiaInadequate hyperemia Hemodynamic Artifacts: Damped pressure waveforms. Damped pressure waveforms. Guide obstruction Guide obstruction Contrast media Contrast media Very small guide (<5F) Very small guide (<5F) Pressure signal drift Pressure signal drift Side holes and ostial ‘pseudostenosis’ Side holes and ostial ‘pseudostenosis’

Rely on FFR Effect of Wire Introducer

Rely on FFR – No Guide Catheter Side Holes or Damping From Nico Pijls

Notch No notch Rely on FFR – Avoid Signal Drift Drift Drift True Gradient

Distal wave form is one key to drift Severe stenosis filters high frequency components – No dichrotic notch Notch No notch

IV vs IC Pharmacologic Hyperemic agents

Ref Diam (mm) % Stenosis for an Cross Sectional Area of 4 mm² < 4 mm² = significant stenosis ? Q: Why can we not use IVUS/OCT for functional assessment? A: A single cross-sectional area does not mean the same thing everywhere.

Single anatomic parameters do not predict FFR with confidence IVUS v FFR

When can you NOT rely on FFR? False Negative FFR 1.Pressure Damping 2.No hyperemia - wrong drug, not mixed not delivered (IV?) or side holes 3.STEMI, culprit. STEMI – non-culprit OK 4. LM + LAD when FFRepicardial < Serial lesion FFR of individual lesion (only gradient useful) False Positive FFR 1. Technical errors (Pressure signal drift,zero, etc.)

ApplicationFFR Ischemia detection, >15 studiesPos <0.75 Neg >0.80 Deferred angioplasty, >8 studies (Key Study: Defer) >0.75 Multivessel FFR guided PCI, LM, Ostial, Jailed Side Branch (Key Study: FAME I, II) (Key Study: Hamilos for LM) (Key Study: Koo BW et al) >0.80 Endpoint of stenting *(IVUS better post stent) >0.94* Coronary Physiologic (FFR) Criteria and Clinical Outcome Studies

62 yo Man, RCA stent occl 2yr ago with return of CP LAD FFR=0.86, 0.87 Now 1V CAD and new approach

DEFER Study – 5 year data JACC 2007;49:2105

RW. 59 yo man with Angina, inferior perf defect 3V CAD – CABG vs PCI? FFR= Questions How Accurate is Stress Test? If PCI needed, FFR directed?

JACC 2010;56:177

FAME study: Death and MI after 2 Years year % FFR-guided Angio-guided P= year (exclusion of small periprocedural infarction) Tonino et al, NEJM 2009, Pijls et al, JACC 2010 Death or MI MI

Incremental QALY FFR Guidance Improves Outcomes FFR Guidance Saves Resources Incremental Cost [$] DES CABG ROTO BMS Balloon Economic Evaluation of FFR-guided PCI in pts with MVD. Fearon WF et al. Circ 2010;122:

FAME: Angiography vs FFR Tonino, P. A. L. et al. J Am Coll Cardiol 2010;55: Angiographic 3- or 2-Vessel Disease does NOT equal Physiologic 3- or 2V CAD 3V CAD Angio = 14% physiol 2V CAD Angio= 43% physiol

FAME II – Ischemia directed PCI+OMT vs OMT alone Stable patients scheduled for 1, 2 or 3 vessel DES stenting FFR in all target lesions When all FFR >0.80 OMT At least 1 stenosis with FFR ≤ 0.80 Randomisation 1:1 PCI + OMT OMT Follow-up after 1, 6 months, 1, 2, 3, 4, and 5 years Randomised Trial Registry 24 50% randomly assigned to FU

25 Rate of Any Revascularisation REGISTRY:OMT only RCT:PCI+OMT RCT:OMT only No. at risk Months after randomisation RCT:PCI+OMT vs. REGISTRY:OMT, p=0.54 RCT:OMT vs. RCT:PCI+OMT = 12.1% vs. 1.7% HR (95% CI): 7.63 ( ); logrank p<.0001 Cumulative incidence (%) FAME II

71 yo Man with typical angina, pos stress, CAD risk factors What’s your best approach?

FFR CFX FFR CFX=0.88

LAD Xience 3.5x18. 2 nd LAD lesion? All done? ? FFR = 0.68

Physiologic Guidance 1. Appropriate need for Stents 2. Objective info re ischemia 3. Eliminates operator uncertainty

Chest pain, No objective evidence ischemia FFR Asymptomatic Patients

Revascularization Approaches per AUC FFR reduces uncertainty and documents appropriateness 2v CAD with prox LAD 3v CAD Isolated LM LM and other CAD

Class IIa Guidelines - ACC/ AHA/ SCAI Class IA Guidelines - ESC The Mandate for Physiologic Guidance arises from a decade of outcomes studies and is supported by guidelines